EPS Creative Health Technology Group Limited
HKEX:3860.HK
0.6 (HKD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 644.615 | 452.906 | 424.656 | 405.445 | 537.408 | 433.004 | 390.423 | 430.13 | 435.206 | 397.968 |
| Cost of Revenue
| 545.358 | 385.059 | 362.101 | 351.414 | 445.207 | 349.535 | 325.955 | 362.946 | 371.059 | 335.36 |
| Gross Profit
| 99.257 | 67.847 | 62.555 | 54.031 | 92.201 | 83.469 | 64.468 | 67.184 | 64.147 | 62.608 |
| Gross Profit Ratio
| 0.154 | 0.15 | 0.147 | 0.133 | 0.172 | 0.193 | 0.165 | 0.156 | 0.147 | 0.157 |
| Reseach & Development Expenses
| 24.309 | 13.04 | 11.249 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 54.994 | 63.144 | 41.357 | 20.011 | 28.748 | 23.987 | 25.71 | 32.827 | 23.789 | 21.514 |
| Selling & Marketing Expenses
| 48.819 | 33.768 | 31.489 | 28.26 | 36.71 | 27.789 | 23.497 | 24.101 | 22.517 | 26.503 |
| SG&A
| 103.813 | 96.912 | 72.846 | 48.271 | 65.458 | 51.776 | 49.207 | 56.928 | 46.306 | 48.017 |
| Other Expenses
| 1.461 | -11.575 | -1.1 | -3.329 | -1.028 | -1.25 | -1.239 | -2.138 | -2.135 | -1.477 |
| Operating Expenses
| 128.122 | 109.189 | 71.746 | 44.942 | 64.43 | 50.526 | 47.968 | 55.314 | 44.944 | 46.483 |
| Operating Income
| -28.865 | -42.366 | -12.007 | 7.272 | 33.096 | 32.834 | 20.04 | 11.885 | 19.327 | 16.329 |
| Operating Income Ratio
| -0.045 | -0.094 | -0.028 | 0.018 | 0.062 | 0.076 | 0.051 | 0.028 | 0.044 | 0.041 |
| Total Other Income Expenses Net
| 4.813 | -7.969 | -9.738 | 0.779 | -5.12 | -0.22 | 0.809 | -2.792 | -3.37 | -3.505 |
| Income Before Tax
| -24.052 | -48.161 | -16.621 | 7.136 | 27.8 | 32.723 | 17.309 | 9.078 | 15.833 | 12.62 |
| Income Before Tax Ratio
| -0.037 | -0.106 | -0.039 | 0.018 | 0.052 | 0.076 | 0.044 | 0.021 | 0.036 | 0.032 |
| Income Tax Expense
| 2.444 | 2.125 | 1.794 | 0.631 | 5.065 | 5.489 | 3.225 | 2.984 | 3.367 | 2.088 |
| Net Income
| -22.066 | -45.737 | -17.636 | 6.505 | 22.735 | 27.234 | 14.084 | 6.094 | 12.466 | 10.532 |
| Net Income Ratio
| -0.034 | -0.101 | -0.042 | 0.016 | 0.042 | 0.063 | 0.036 | 0.014 | 0.029 | 0.026 |
| EPS
| -0.044 | -0.092 | -0.035 | 0.013 | 0.046 | 0.055 | 0.029 | 0.016 | 0.033 | 0.021 |
| EPS Diluted
| -0.044 | -0.092 | -0.035 | 0.013 | 0.046 | 0.055 | 0.029 | 0.016 | 0.033 | 0.021 |
| EBITDA
| -14.846 | -37.883 | -8.826 | 10.13 | 30.154 | 33.918 | 18.458 | 10.532 | 18.905 | 16.874 |
| EBITDA Ratio
| -0.023 | -0.084 | -0.021 | 0.025 | 0.056 | 0.078 | 0.047 | 0.024 | 0.043 | 0.042 |